US EditionPublished • loading... • Updated
Mpox: How Tecovirimat Could Be Prescribed to Patients in the Absence of Proof of Its Effectivenesslast News From Haiti: Politics, Security, Economy, Culture.
Summary by Haiti24
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A vial of Tecovirimat, used for the treatment of mpox, in New York, on July 19, 2022. YUKI IWAMURA / AFP Can we still "save the tecovirimat soldier?", asked by telephone, at the end of 2024, the epidemiologist Antoine Flahault, at the University of Paris Cité, about this medicine on which the World Health Organization put in 2022 to stem outbreaks of the monkeypox virus. The answer fell with the presentation, at the 13th conference of the Intern…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
